Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Assets: 2023-2025

Historic Assets for Upstream Bio (UPB) over the last 1 years, with Sep 2025 value amounting to $391.2 million.

  • Upstream Bio's Assets rose 68.11% to $391.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $391.2 million, marking a year-over-year increase of 68.11%. This contributed to the annual value of $481.7 million for FY2024, which is 311.03% up from last year.
  • Upstream Bio's Assets amounted to $391.2 million in Q3 2025, which was down 6.97% from $420.5 million recorded in Q2 2025.
  • Upstream Bio's Assets' 5-year high stood at $481.7 million during Q4 2024, with a 5-year trough of $117.2 million in Q4 2023.
  • Moreover, its 3-year median value for Assets was $405.9 million (2025), whereas its average is $349.9 million.
  • Data for Upstream Bio's Assets shows a peak YoY soared of 311.03% (in 2024) over the last 5 years.
  • Over the past 3 years, Upstream Bio's Assets (Quarterly) stood at $117.2 million in 2023, then spiked by 311.03% to $481.7 million in 2024, then spiked by 68.11% to $391.2 million in 2025.
  • Its Assets stands at $391.2 million for Q3 2025, versus $420.5 million for Q2 2025 and $456.2 million for Q1 2025.